Philips and Imricor Medical Systems today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The configuration combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, which the companies said enables an MR-guided workflow for cardiac intervention without compromising on MR field strength.
The configuration includes Philips' Cardiac MR Suite, featuring SmartHeart AI-powered cardiac planning and cardiac imaging applications alongside Imricor's NorthStar iMR mapping and guidance system, Advantage-MR EP Recorder/Stimulator and Vision-MR family of electrophysiology catheters. Together, these technologies enable physicians to visualize cardiac anatomy and arrhythmia substrate, actively track catheters, perform electroanatomical mapping, assess lesion formation and evaluate treatment response throughout procedures within Philips' 1.5T MR environment.
For hospitals, the iMR lab solution provides a turnkey platform for MR-guided cardiac intervention, bringing together advanced imaging, intelligent workflows and MR-compatible interventional technologies. The solution is built on Philips' BlueSeal helium-free MRI technology, reducing siting complexity and enabling installation closer to cardiology departments, helping support adoption today while establishing a scalable foundation for future iMR-guided procedures.
The iMR lab solution will be showcased in Munich at ESC Congress 2026 and is commercially available immediately in CE-marked markets and, in some configurations, the U.S. Further Imricor configurations are expected to become available in the U.S. and additional markets, subject to regulatory clearances.
